| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/05/2010 | US20100197933 Process for the Preparation of Candesartan Cilexetil |
| 08/05/2010 | US20100197918 2,4-pyrimidinediamine compounds and their uses |
| 08/05/2010 | US20100197908 Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds |
| 08/05/2010 | US20100197871 Ligands for copper-catalyzed azide-alkyne cycloaddition reactions |
| 08/05/2010 | US20100197708 Indole compounds |
| 08/05/2010 | US20100197700 5-ht7 receptor antagonists |
| 08/05/2010 | US20100197687 Indoles Useful in the Treatment of Inflammation |
| 08/05/2010 | US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 08/05/2010 | US20100197672 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto |
| 08/05/2010 | US20100197671 Phenyl amino pyrimidine compounds and uses thereof |
| 08/05/2010 | US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 08/05/2010 | US20100197664 Novel b1-antagonists |
| 08/05/2010 | US20100197655 Sulfonamide derivatives |
| 08/05/2010 | US20100197654 Triazine kinase inhibitors |
| 08/05/2010 | US20100197651 Pyridazinone compounds |
| 08/05/2010 | US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators |
| 08/05/2010 | US20100197644 Chemical Compounds 572 |
| 08/05/2010 | US20100197562 Functionally selective alpha2c adrenoreceptor agonists |
| 08/05/2010 | US20100197031 Functionalized expanded porphyrins |
| 08/05/2010 | US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase |
| 08/05/2010 | CA2751239A1 Azetidines as histamine h3 receptor antagonists |
| 08/05/2010 | CA2749884A1 Bicyclic pyrazolo-heterocycles |
| 08/04/2010 | EP2213669A1 Crystalline imidazol-5-carboxylic acid derivate |
| 08/04/2010 | EP2213660A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 08/04/2010 | EP2213167A1 Anthranilamide derivatives and their use for the control of insects and acari |
| 08/04/2010 | EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 08/04/2010 | EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
| 08/04/2010 | EP2212297A1 Inhibitors of protein kinases |
| 08/04/2010 | EP2212283A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 08/04/2010 | EP2212282A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 08/04/2010 | EP2010506B1 Diazepan derivatives modulators of chemokine receptors |
| 08/04/2010 | EP1831201B1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 08/04/2010 | EP1343769B1 Benzoylpyridazines |
| 08/04/2010 | CN1360502B Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
| 08/04/2010 | CN101796045A New chemical compounds |
| 08/04/2010 | CN101796033A Substituted piperazines as CB1 antagonists |
| 08/04/2010 | CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 08/04/2010 | CN101795711A chemical linkers and cleavable substrates and conjugates thereof |
| 08/04/2010 | CN101792440A Quinazolinone derivatives, preparation and application thereof |
| 08/04/2010 | CN101126022B Bi-vinyl anthracenes luminescent compounds |
| 08/03/2010 | US7767852 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 08/03/2010 | US7767828 preferential dipeptidyl peptidase-IV inhibitors such as (2R)-1-{2-[(3S)-Pyrrolidin- 3-methyl-3-ylamino]- acetyl}-pyrrolidine-2- boronic acid, used as antidiabetic agents |
| 08/03/2010 | US7767812 Crystals of pyrimidine compound and process for producing the same |
| 08/03/2010 | US7767704 viricides such as N-(3-Chloropropyl)-1-methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-carboxamide, used for treating cytomegalovirus infections in humans or animals |
| 08/03/2010 | US7767680 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders |
| 08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/03/2010 | US7767675 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 08/03/2010 | US7767672 Aminopyrimidines useful as kinase inhibitors |
| 08/03/2010 | US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer |
| 08/03/2010 | US7767667 Pesticidal heterocycles |
| 08/03/2010 | CA2598788C Indoline-sulfonamides compounds |
| 08/03/2010 | CA2526228C Quinoline derivatives as phosphodiesterase inhibitors |
| 08/03/2010 | CA2512926C Methods and compositions for inhibition of angiogenesis |
| 07/29/2010 | WO2010085749A2 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability |
| 07/29/2010 | WO2010085684A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | WO2010085246A1 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors |
| 07/29/2010 | WO2010084979A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/29/2010 | WO2010084428A1 Substituted pyrazinone amides |
| 07/29/2010 | WO2010083649A1 Bisarylurea derivatives and their use |
| 07/29/2010 | WO2010083633A1 Compounds uesed for anti-hypertension, preparation methods, compositions and uses thereof |
| 07/29/2010 | WO2010065802A3 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds |
| 07/29/2010 | WO2010044585A3 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 07/29/2010 | WO2010039545A3 1,2-benzisothiazolinone and isoindolinone derivatives |
| 07/29/2010 | US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity |
| 07/29/2010 | US20100190996 Process for the Preparation of Losartan |
| 07/29/2010 | US20100190983 Process for preparing voriconazole |
| 07/29/2010 | US20100190980 Pyrazinamide compound |
| 07/29/2010 | US20100190977 4-phenylamino-quinazolin-6-yl-amides |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190826 Benzimidazole derivative |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190802 Carboxamide compounds and methods for using the same |
| 07/29/2010 | US20100190789 Piperidine/piperazine derivatives |
| 07/29/2010 | US20100190784 Organic Compounds |
| 07/29/2010 | US20100190783 Triazolone derivatives |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190777 Compounds and methods for kinase modulation, and indications therefor |
| 07/29/2010 | US20100190770 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | US20100190768 Novel fused pyrole derivative |
| 07/29/2010 | US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same |
| 07/29/2010 | US20100187520 Light emitting device material and light emitting device |
| 07/29/2010 | US20100187505 Benzanthracene derivatives for organic electroluminescent devices |
| 07/29/2010 | CA2749700A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | CA2749217A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | CA2748587A1 Substituted pyrazinone amides |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210888A2 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 07/28/2010 | EP2210887A1 Bis resorcinyl triazine derivatives as protecting agents against UV radiation |
| 07/28/2010 | EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
| 07/28/2010 | EP2209376A1 Novel seh inhibitors and their use |
| 07/28/2010 | EP2209373A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN101790526A 5-heteroaryl substituted indazoles as kinase inhibitors |
| 07/28/2010 | CN101790525A pharmaceutical compounds |